Abstract
BackgroundValvular involvement is the most common cardiac manifestation in the antiphospholipid syndrome (APS) and has been associated to high risk of arterial thrombotic events, presence of cardiovascular risk factors, livedo...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
